Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
9 pending office actions • 8 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Children's National Medical Center has 9 pending office actions in Biotechnology & Pharmaceuticals. Those actions involve 9 distinct examiners and 8 distinct art units, indicating that the portfolio's prosecution activity is distributed across nearly as many examination assignments as actions.
CARTER, SANDRA DILLAHUNT is the busiest examiner, with 1 pending action. No examiner accounts for a concentrated share of the recorded activity, so counsel should review the matters individually rather than assume that one examiner relationship defines the portfolio. The spread across art units also supports matter-specific claim and prior-art analysis.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (33%) |
| §103 only | 2 (22%) |
| §102 only | 1 (11%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CARTER, SANDRA DILLAHUNT | 1 | 56.2% | +28.6% |
| DIETRICH, JOSEPH M | 1 | 81.1% | +8.8% |
| PARK, PATRICIA JOO YOUNG | 1 | 57.9% | +14.7% |
| BOSQUES, EDELMIRA | 1 | 62.8% | +19.7% |
| ROONEY, NORA MAUREEN | 1 | 60.5% | +23.4% |
| GOLOVAN, MARK | 1 | 66.7% | +50.0% |
| HANEY, AMANDA MARIE | 1 | 36.5% | +45.0% |
| ALABI, OYELEYE A | 1 | 83.9% | +23.8% |
| MIDDLETON, DANAYA L | 1 | 49.5% | +48.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686890 | DEVELOPMENT OF A BEAT-TO-BEAT FETAL ELECTROCARDIOGRAM | DIETRICH, JOSEPH M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561080 | BURN INJURY MANAGEMENT USING A CALCULATION OF TOTAL BODY SURFACE AREA BURNED | PARK, PATRICIA JOO YOUNG | — |
| 18560257 | RETRACTABLE LOW-PROFILE PEDIATRIC GASTROSTOMY TUBE AND USES THEREOF | BOSQUES, EDELMIRA | — |
| 18259529 | CONNECTION PROTECTOR, SECUREMENT SYSTEM HAVING THE CONNECTION PROTECTOR AND USES THEREOF | GOLOVAN, MARK | — |
| 18251654 | CIRCULATING miRNA AND PROTEIN BIOMARKERS FOR FACIOSCAPULOHUMERAL DYSTROPHY | HANEY, AMANDA MARIE | — |
| 18301056 | REVERSE-PHASE HIGH PRESSURE LIQUID CHROMATOGRAPHY METHODS FOR MEASURING AMINO ACIDS, AMMONIUM, AND GLUTATHIONE CONCENTRATIONS IN BIOLOGICAL SAMPLES | ALABI, OYELEYE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17425130 | WHOLE CELL TUMOR VACCINES AND METHODS OF USE THEROF | MIDDLETON, DANAYA L | 28d |
| 18707822 | TARGETING APOE ENHANCES T-CELL KILLING IN CANCER IMMUNOTHERAPY | CARTER, SANDRA DILLAHUNT | — |
| 18561080 | BURN INJURY MANAGEMENT USING A CALCULATION OF TOTAL BODY SURFACE AREA BURNED | PARK, PATRICIA JOO YOUNG | — |
| 18560257 | RETRACTABLE LOW-PROFILE PEDIATRIC GASTROSTOMY TUBE AND USES THEREOF | BOSQUES, EDELMIRA | — |
| 18219930 | NANOPARTICLE-MEDIATED IMMUNE CELL MANUFACTURE AND USE THEREOF | ROONEY, NORA MAUREEN | — |
| 18259529 | CONNECTION PROTECTOR, SECUREMENT SYSTEM HAVING THE CONNECTION PROTECTOR AND USES THEREOF | GOLOVAN, MARK | — |
| 18251654 | CIRCULATING miRNA AND PROTEIN BIOMARKERS FOR FACIOSCAPULOHUMERAL DYSTROPHY | HANEY, AMANDA MARIE | — |
| 18301056 | REVERSE-PHASE HIGH PRESSURE LIQUID CHROMATOGRAPHY METHODS FOR MEASURING AMINO ACIDS, AMMONIUM, AND GLUTATHIONE CONCENTRATIONS IN BIOLOGICAL SAMPLES | ALABI, OYELEYE A | — |
| Art Unit | Apps |
|---|---|
| 1674 | 2 |
| 3796 | 1 |
| 3798 | 1 |
| 3772 | 1 |
| 1641 | 1 |
| 3783 | 1 |
| 1682 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18707822 | TARGETING APOE ENHANCES T-CELL KILLING IN CANCER IMMUNOTHERAPY | CARTER, SANDRA DILLAHUNT | 1674 | §102§103§112DP | Non-Final OA | — | Pending | May 06, 2024 |
| 18686890 | DEVELOPMENT OF A BEAT-TO-BEAT FETAL ELECTROCARDIOGRAM | DIETRICH, JOSEPH M | 3796 | §103 | Final Rejection | — | Pending | Feb 27, 2024 |
| 18561080 | BURN INJURY MANAGEMENT USING A CALCULATION OF TOTAL BODY SURFACE AREA BURNED | PARK, PATRICIA JOO YOUNG | 3798 | §101§103 | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18560257 | RETRACTABLE LOW-PROFILE PEDIATRIC GASTROSTOMY TUBE AND USES THEREOF | BOSQUES, EDELMIRA | 3772 | §102§103 | Final Rejection | — | Pending | Nov 10, 2023 |
| 18219930 | NANOPARTICLE-MEDIATED IMMUNE CELL MANUFACTURE AND USE THEREOF | ROONEY, NORA MAUREEN | 1641 | §102 | Non-Final OA | — | Pending | Jul 10, 2023 |
| 18259529 | CONNECTION PROTECTOR, SECUREMENT SYSTEM HAVING THE CONNECTION PROTECTOR AND USES THEREOF | GOLOVAN, MARK | 3783 | §102§103§112 | Non-Final OA | — | Pending | Jun 27, 2023 |
| 18251654 | CIRCULATING miRNA AND PROTEIN BIOMARKERS FOR FACIOSCAPULOHUMERAL DYSTROPHY | HANEY, AMANDA MARIE | 1682 | §101§112 | Non-Final OA | — | Pending | May 03, 2023 |
| 18301056 | REVERSE-PHASE HIGH PRESSURE LIQUID CHROMATOGRAPHY METHODS FOR MEASURING AMINO ACIDS, AMMONIUM, AND GLUTATHIONE CONCENTRATIONS IN BIOLOGICAL SAMPLES | ALABI, OYELEYE A | 1758 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 14, 2023 |
| 17425130 | WHOLE CELL TUMOR VACCINES AND METHODS OF USE THEROF | MIDDLETON, DANAYA L | 1674 | §103 | Final Rejection | 28d | Pending | Jul 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChildren's National Medical Center has 9 pending office actions as of October 2026, spread across 8 art units and 9 examiners.
Sandra Dillahunt Carter has the most, with 1 of Children's National Medical Center's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
